What Should Be Done To Tackle Ghostwriting in the Medical Literature?
暂无分享,去创建一个
Elizabeth Wager | Karen L Woolley | Peter C Gøtzsche | Karen L. Woolley | Adam Jacobs | Cindy W. Hamilton | J. Kassirer | P. Gøtzsche | E. Wager | A. Gertel | Adam Jacobs | Jerome P Kassirer | Art Gertel | Cindy Hamilton | Art Gertel
[1] E. von Elm,et al. Full publication of results initially presented in abstracts. , 2007, The Cochrane database of systematic reviews.
[2] Douglas G Altman,et al. Ghost Authorship in Industry-Initiated Randomised Trials , 2007, PLoS medicine.
[3] Karen L Woolley,et al. Declaration of medical writing assistance in international peer-reviewed publications. , 2006, JAMA.
[4] D. Rennie,et al. Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. , 1998, JAMA.
[5] Ermenegyldo Munhoz Junior. Requisitos uniformes para manuscritos submetidos a periódicos biomédicos: escrevendo e editando para publicações biomédicas , 2006 .
[6] D. Rennie,et al. When authorship fails. A proposal to make contributors accountable. , 1997, JAMA.
[7] Richard Smith,et al. Patient Safety Requires a New Way to Publish Clinical Trials , 2006, PLoS clinical trials.
[8] Melissa S. Anderson,et al. Scientists behaving badly , 2005, Nature.
[9] David R Hadden,et al. The Trouble with Medical Journals , 2007, The Ulster Medical Journal.
[10] E. Wager. Authors, Ghosts, Damned Lies, and Statisticians , 2007, PLoS medicine.
[11] Robert W. Matthews,et al. Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication , 2010, Journal of pharmacology & pharmacotherapeutics.
[12] D. Rennie,et al. Prevalence of honorary and ghost authorship in Cochrane reviews. , 2002, JAMA.
[13] Richard Smith,et al. Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies , 2005, PLoS medicine.
[14] Harlan M Krumholz,et al. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. , 2008, JAMA.
[15] Elizabeth Wager,et al. Good publication practice for pharmaceutical companies , 2003, Current medical research and opinion.
[16] T. Stossel,et al. International Society for Medical Publication Professionals (ISMPP)position statement: the role of the professional medical writer , 2007, Current medical research and opinion.
[17] Karen L Woolley,et al. Goodbye Ghostwriters!: How to work ethically and efficiently with professional medical writers. , 2006, Chest.
[18] E. Wager,et al. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications , 2005, Current medical research and opinion.
[19] Carlos Alberto Guimarães,et al. Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication , 2008, Revista espanola de cardiologia.
[20] H. Chaiklin. On the Take: How Medicine??s Complicity With Big Business Can Endanger Your Health , 2006 .
[21] R. Fletcher. Ghost writing initiated by commercial companies , 2005, Journal of General Internal Medicine.
[22] Lisa Bero,et al. Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation , 2008, PLoS medicine.
[23] Valéria Cavalcanti Rolla,et al. On the Take: How Medicine's Complicity with Big Business Can Endanger Your Health , 2004 .
[24] T. Cymet,et al. The Truth about Drug Companies: How They Deceive Us and What to Do about It , 2006 .